COGT
Price
$5.98
Change
+$0.34 (+6.03%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
680.86M
68 days until earnings call
REGN
Price
$483.07
Change
-$1.86 (-0.38%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
52.15B
56 days until earnings call
Interact to see
Advertisement

COGT vs REGN

Header iconCOGT vs REGN Comparison
Open Charts COGT vs REGNBanner chart's image
Cogent Biosciences
Price$5.98
Change+$0.34 (+6.03%)
Volume$34.82K
Capitalization680.86M
Regeneron Pharmaceuticals
Price$483.07
Change-$1.86 (-0.38%)
Volume$15.78K
Capitalization52.15B
COGT vs REGN Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. REGN commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a StrongBuy and REGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (COGT: $5.98 vs. REGN: $483.07)
Brand notoriety: COGT: Not notable vs. REGN: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 189% vs. REGN: 130%
Market capitalization -- COGT: $680.86M vs. REGN: $52.15B
COGT [@Biotechnology] is valued at $680.86M. REGN’s [@Biotechnology] market capitalization is $52.15B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileREGN’s FA Score has 1 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • REGN’s FA Score: 1 green, 4 red.
According to our system of comparison, REGN is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 5 TA indicator(s) are bullish while REGN’s TA Score has 4 bullish TA indicator(s).

  • COGT’s TA Score: 5 bullish, 3 bearish.
  • REGN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, COGT is a better buy in the short-term than REGN.

Price Growth

COGT (@Biotechnology) experienced а +8.53% price change this week, while REGN (@Biotechnology) price change was -20.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2025.

REGN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REGN($52.2B) has a higher market cap than COGT($681M). COGT YTD gains are higher at: -27.692 vs. REGN (-31.735). REGN has higher annual earnings (EBITDA): 5.53B vs. COGT (-284.04M). COGT has less debt than REGN: COGT (17.1M) vs REGN (2.71B). REGN has higher revenues than COGT: REGN (14.1B) vs COGT (0).
COGTREGNCOGT / REGN
Capitalization681M52.2B1%
EBITDA-284.04M5.53B-5%
Gain YTD-27.692-31.73587%
P/E RatioN/A12.28-
Revenue014.1B-
Total Cash246MN/A-
Total Debt17.1M2.71B1%
FUNDAMENTALS RATINGS
COGT vs REGN: Fundamental Ratings
COGT
REGN
OUTLOOK RATING
1..100
133
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
3
Undervalued
PROFIT vs RISK RATING
1..100
73100
SMR RATING
1..100
9653
PRICE GROWTH RATING
1..100
8465
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

REGN's Valuation (3) in the Biotechnology industry is significantly better than the same rating for COGT (81) in the Miscellaneous industry. This means that REGN’s stock grew significantly faster than COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (73) in the Miscellaneous industry is in the same range as REGN (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to REGN’s over the last 12 months.

REGN's SMR Rating (53) in the Biotechnology industry is somewhat better than the same rating for COGT (96) in the Miscellaneous industry. This means that REGN’s stock grew somewhat faster than COGT’s over the last 12 months.

REGN's Price Growth Rating (65) in the Biotechnology industry is in the same range as COGT (84) in the Miscellaneous industry. This means that REGN’s stock grew similarly to COGT’s over the last 12 months.

REGN's P/E Growth Rating (97) in the Biotechnology industry is in the same range as COGT (100) in the Miscellaneous industry. This means that REGN’s stock grew similarly to COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTREGN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
56%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
55%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 17 days ago
61%
Declines
ODDS (%)
Bearish Trend 15 days ago
84%
Bearish Trend 2 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
56%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APFDX22.050.23
+1.05%
Artisan Global Discovery Investor
FTANX12.10N/A
N/A
Fidelity Asset Manager 30%
LLINX16.66N/A
N/A
Longleaf Partners International
FEIKX77.53N/A
N/A
Fidelity Equity-Income K
UDPSX62.74N/A
N/A
ProFunds Ultra Dow 30 Svc

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-2.59%
SPHDF - COGT
63%
Loosely correlated
N/A
XNCR - COGT
54%
Loosely correlated
-0.44%
IDYA - COGT
53%
Loosely correlated
-2.50%
RARE - COGT
52%
Loosely correlated
+0.58%
CRNX - COGT
52%
Loosely correlated
+0.78%
More

REGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, REGN has been loosely correlated with CRNX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if REGN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REGN
1D Price
Change %
REGN100%
-0.60%
CRNX - REGN
43%
Loosely correlated
+0.78%
ROIV - REGN
43%
Loosely correlated
-0.31%
IDYA - REGN
43%
Loosely correlated
-2.50%
COGT - REGN
40%
Loosely correlated
-2.59%
NTLA - REGN
40%
Loosely correlated
-0.26%
More